Clearing the brain's amyloid cobwebs - PubMed (original) (raw)

Review

. 2001 Oct 25;32(2):177-80.

doi: 10.1016/s0896-6273(01)00475-5.

Affiliations

• PMID: 11683988
• DOI: 10.1016/s0896-6273(01)00475-5

Free article

Review

Clearing the brain's amyloid cobwebs

D J Selkoe. Neuron. 2001.

Free article

Abstract

Elevated cerebral levels of amyloid beta-protein occur universally in Alzheimer's disease, yet only a few patients show evidence of increased Abeta production. Therefore, defects in proteases that degrade Abeta could underlie some or many cases of familial and sporadic AD. This previously neglected topic has begun receiving serious attention. Understanding how proteolysis regulates Abeta levels in the cerebral cortex has implications for both the pathogenesis and the treatment of this protean disorder.

PubMed Disclaimer

Similar articles

• Peptidases, proteases and amyloid beta-peptide catabolism.
  Hersh LB. Hersh LB. Curr Pharm Des. 2003;9(6):449-54. doi: 10.2174/1381612033391676. Curr Pharm Des. 2003. PMID: 12570808 Review.
• Amyloid beta degradation: a challenging task for brain peptidases.
  Morelli L, Bulloj A, Leal MC, Castaño EM. Morelli L, et al. Subcell Biochem. 2005;38:129-45. doi: 10.1007/0-387-23226-5_6. Subcell Biochem. 2005. PMID: 15709476 Review.
• Regulation of amyloid beta-peptide levels by enzymatic degradation.
  Mukherjee A, Hersh LB. Mukherjee A, et al. J Alzheimers Dis. 2002 Oct;4(5):341-8. doi: 10.3233/jad-2002-4501. J Alzheimers Dis. 2002. PMID: 12446966
• Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
  Higuchi M, Iwata N, Saido TC. Higuchi M, et al. Biochim Biophys Acta. 2005 Aug 1;1751(1):60-7. doi: 10.1016/j.bbapap.2005.02.013. Epub 2005 Mar 17. Biochim Biophys Acta. 2005. PMID: 16054018 Review.
• Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
  Liu Y, Hua Q, Lei H, Li P. Liu Y, et al. J Ethnopharmacol. 2011 Sep 2;137(2):1035-46. doi: 10.1016/j.jep.2011.07.031. Epub 2011 Jul 20. J Ethnopharmacol. 2011. PMID: 21798326

Cited by

• A Potential Link between Myeloperoxidase Modified LDL, Atherosclerosis and Depression.
  Daher J. Daher J. Int J Mol Sci. 2024 Aug 13;25(16):8805. doi: 10.3390/ijms25168805. Int J Mol Sci. 2024. PMID: 39201490 Free PMC article. Review.
• Novel Insights into the Link Between Myeloperoxidase Modified LDL, LOX-1, and Neuroserpin in Stroke.
  El-Hajjar L, Miranda E, El-Sabban M, Daher J. El-Hajjar L, et al. Rev Cardiovasc Med. 2023 Dec 15;24(12):354. doi: 10.31083/j.rcm2412354. eCollection 2023 Dec. Rev Cardiovasc Med. 2023. PMID: 39077081 Free PMC article.
• Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease.
  Meur S, Mukherjee S, Roy S, Karati D. Meur S, et al. Mol Neurobiol. 2024 May 30. doi: 10.1007/s12035-024-04257-7. Online ahead of print. Mol Neurobiol. 2024. PMID: 38816674 Review.
• An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer's Disease.
  Ratan Y, Rajput A, Maleysm S, Pareek A, Jain V, Pareek A, Kaur R, Singh G. Ratan Y, et al. Biomedicines. 2023 May 8;11(5):1398. doi: 10.3390/biomedicines11051398. Biomedicines. 2023. PMID: 37239068 Free PMC article. Review.
• Amyloid-beta aggregation implicates multiple pathways in Alzheimer's disease: Understanding the mechanisms.
  Iliyasu MO, Musa SA, Oladele SB, Iliya AI. Iliyasu MO, et al. Front Neurosci. 2023 Apr 11;17:1081938. doi: 10.3389/fnins.2023.1081938. eCollection 2023. Front Neurosci. 2023. PMID: 37113145 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations